Latest Market News
Shares of Match Group Inc. MTCH, +2.20% surged 5.2% in premarket trading Friday, after the data apps company after Alphabet Inc.’s GOOG, -1.29% GOOGL, -1.34% Google made “various concessions” regarding Match’s complaints. As a result, Match said it has withdrawn its request for a temporary restraining order, which it said last week that it would […]
Shares of Zymeworks Inc. ZYME, +2.92% rallied 1.5% in morning trading Friday, after the biopharmaceutical company said it rejected the “unsolicited, opportunistic, non-binding” $10.50-per-share buyout bid by activist investor All Blue Falcons FZE. The company said it determined that the bid by the UAE-based investment holding company “significantly undervalues” the company and its prospects, and […]
Type: Bullish BounceKey Levels:Resistance: 50906Pivot: 50469Support: 50300Preferred Case:With price moving above our ichimoku cloud , we have a bullish bias that price will rise to our 1st resistance at 50906 in line with the 61.8% Fibonacci projection , 100% fibonacci projection , -27.2 fibonacci expansion and overlap resistance from our pivot of 50469 in line […]
Retail Activity Rises Despite Inflation The British Pound has seen strong demand again today following an unexpectedly strong set of retail sales for April. The data, released this morning, showed that retail sales grew by 1.3% last month. This was in stark contrast to the -0.3% reading the market was expecting and marks a sharp […]
Shares of Ollie’s Bargain Outlet Holdings Inc. OLLI, -1.94% slipped 0.3% in morning trading Friday, but were outperforming the retail sector by a wide margin, after BofA Securities analyst Jason Haas swung to bullish from bearish on the closeout retailer, citing signs suggesting availability of closeout merchandise has “meaningfully improved” over the past several months. […]
Shares of Novavax Inc. NVAX, -8.57% sank 8.8% in midday trading Friday, after BofA Securities analyst Alec Stranahan recommended investors avoid the COVID-19 vaccine maker, citing a bearish view on continued booster use and increasing competition in the respiratory syncytial virus (RSV) and flu markets. Stranahan initiated coverage of Novavax at underperform and with a […]